| Dr Kirit J Desai, MD | |
|
4021 S 700 E, Suite 300, Salt Lake City, UT 84107-2184 | |
| (800) 453-3030 | |
| Not Available |
| Full Name | Dr Kirit J Desai |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Location | 4021 S 700 E, Salt Lake City, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629269188 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | MD00041515 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kirit J Desai, MD 2735 63rd St, Downers Grove, IL 60516-1663 Ph: (630) 220-1985 | Dr Kirit J Desai, MD 4021 S 700 E, Suite 300, Salt Lake City, UT 84107-2184 Ph: (800) 453-3030 |
News Archive
Researchers at the University of Texas Medical Branch at Galveston, in collaboration with The University of Texas Health Science Center at Houston (UTHealth), Baylor College of Medicine and the Georgia Regents University, report for the first time that the cholesterol-lowering drug simvastatin inhibits the growth of human uterine fibroid tumors.
BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced today that the data from its completed Phase 2 clinical study of OncoVEX (GM-CSF) for the treatment of advanced melanoma has been published in the Journal of Clinical Oncology (JCO). The previously announced top line results report a high objective durable response rate and a high complete response rate, combined with a relatively benign side effect profile.
One of Southern California's largest hospital systems is teaming up with hundreds of doctors in a new alliance designed to better manage patient care, improve medical outcomes and reduce costs. Under the partnership with Providence Health & Services of Southern California, doctors will share and analyze data about diabetes, congestive heart failure and other conditions to identify effective practices and eliminate inefficiencies that drive up expenses.
Synosia Therapeutics today announced interim positive data from a Phase IIa clinical study of an adenosine 2a (A2a) receptor antagonist (SYN115) in Parkinson's disease.
› Verified 7 days ago
Caitlin Marie Bolender, MD Dermatology Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 4a330, Salt Lake City, UT 84132 Phone: 801-581-5509 | |
Dr. Lana Ngoc Pho, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-587-6340 Fax: 801-587-6346 | |
Justin F Thulin, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1151 E 3900 S, Parkview Building B 259, Salt Lake City, UT 84124 Phone: 801-266-7325 Fax: 801-281-2263 | |
Bahman Sotoodian, MD, FRCP(C), FAAD Dermatology Medicare: Medicare Enrolled Practice Location: 440 W 200 S Ste 250, Salt Lake City, UT 84101 Phone: 801-595-1600 | |
Amber R. Jimenez, MD Dermatology Medicare: Medicare Enrolled Practice Location: 30 N 1900 E # 4a330, Salt Lake City, UT 84132 Phone: 015-816-4658 | |
Dr. Douglas L Powell, M.D. Dermatology Medicare: May Accept Medicare Assignments Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-581-2955 | |
David A Wada, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 50 N Medical Dr # E13, Salt Lake City, UT 84132 Phone: 801-581-2955 |